BenchSci, a global leader in machine learning applications for novel medicine development, today announced a $63 million Series C (US $50 Million) funding round led by Inovia Capital and TCV, with participation from existing investors.

Since inception, the firm has built a track record of successfully backing public and private businesses that have developed into dominant industry players across internet, software, FinTech, and enterprise IT.   “BenchSci is well-positioned to be the category-defining technology platform for the industry, and we look forward to working with Liran and his team to transform this industry.”

Benchsci Raises $63 Million Series C To Solve Pharma's Biggest R&D Challenges With Ai-Powered Software Platform

Description

Company Information

FundzWatch™ Score

Funding Insights